MCTC Holdings

MCTC Holdings was an OTC-listed cannabinoid science and product-development company focused on hemp extract infusion, delivery, and bioavailability technologies. The company operated in the cannabis and consumer wellness space rather than traditional prescription biopharma, and it emphasized polymeric nanoparticle, nanofiber, and infusion systems intended for beverages, foods, and other hemp-derived products. In 2020, MCTC acquired Lelantos Biotech and subsequently completed a corporate name change to Cannabis Global, with the ticker changing from MCTC to CBGL. Available public records indicate that MCTC Holdings no longer operates under that legacy name and should be treated primarily as a former corporate name of Cannabis Global rather than a standalone active company. Its health relevance is adjacent to life sciences through cannabinoid formulation and delivery technology, but it does not appear to have had a conventional drug-development pipeline.